BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7316614)

  • 1. [Comparison of inactivated rabies vaccines obtained from diploid and polyploid heterologous cells (Hak, BHK, and Vero)].
    Atanasiu P; Perrin P; Segre L; Manganas O
    Arch Inst Pasteur Tunis; 1981; 58(3):401-21. PubMed ID: 7316614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation and comparative studies of inactivated rabies vaccines obtained in the heterologous diploid and polyploid cells (HAK, BHK and VERO).
    Atanasiu P; Perrin P; Segre L; Manganas O
    Dev Biol Stand; 1981; 50():173-82. PubMed ID: 7341292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of various immunochemical, biochemical and biological methods for the analysis of rabies virus production in tissue cultures.
    Adamovicz P; Aguilon F; David A; Le Fur R; Mazert MC; Perrin P; Reculard P; Sureau P
    Dev Biol Stand; 1983; 55():191-7. PubMed ID: 6677532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production and control of rabies vaccines made on diploid cells.
    Wiktor TJ
    Dev Biol Stand; 1976 Dec 13-15; 37():265-6. PubMed ID: 1031688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rabies vaccine produced in a non-tumorigenic rabbit cell line.
    Sureau P; Perrin P; Horaud F
    Dev Biol Stand; 1985; 60():133-9. PubMed ID: 4043531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zonal-centrifuged human diploid cell rabies vaccine.
    Majer M; Hilfenhaus J; Mauler R; Hennessen W
    Dev Biol Stand; 1976 Dec 13-15; 37():267-71. PubMed ID: 801472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BHK-21 cell culture rabies vaccine: immunogenicity of a candidate vaccine for humans.
    Lalosević D; Lalosević V; Lazarević-Ivanc Lj; Knezević I
    Dev Biol (Basel); 2008; 131():421-9. PubMed ID: 18634504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Freeze-drying of a purified human diploid cell rabies vaccine.
    Majer M; Herrmann A; Hilfenhaus J; Reichert E; Mauler R; Hennessen W
    Dev Biol Stand; 1976 Oct; 36():285-9. PubMed ID: 1030426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vero-cell rabies vaccine produced using serum-free medium.
    Frazatti-Gallina NM; Mourão-Fuches RM; Paoli RL; Silva ML; Miyaki C; Valentini EJ; Raw I; Higashi HG
    Vaccine; 2004 Dec; 23(4):511-7. PubMed ID: 15530700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and replication of rabies virus in C6 rat glioma cells (clone CCL-107).
    Bordignon J; Piza AT; Alvarez-Silva M; Caporale GM; Carrieri ML; Kotait I; Zanetti CR
    Biologicals; 2001 Jun; 29(2):67-73. PubMed ID: 11580211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardization of an enzyme immunoassay for the in vitro potency assay of inactivated tissue culture rabies vaccines: determination of the rabies virus glycoprotein with polyclonal antisera.
    Thraenhart O; Ramakrishnan K
    J Biol Stand; 1989 Oct; 17(4):291-309. PubMed ID: 2613705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of inactivated human rabies vaccines: biochemical characterization and genetic identification of virus strains.
    Finke S; Karger A; Freuling C; Müller T
    Vaccine; 2012 May; 30(24):3603-9. PubMed ID: 22469862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of homologous vs. heterologous challenge virus strains on the serological test results of rabies virus neutralizing assays.
    Moore SM; Ricke TA; Davis RD; Briggs DJ
    Biologicals; 2005 Dec; 33(4):269-76. PubMed ID: 16168666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor.
    Trabelsi K; Rourou S; Loukil H; Majoul S; Kallel H
    J Biotechnol; 2006 Jan; 121(2):261-71. PubMed ID: 16153733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical trial of YU BHK Rabivak vaccine against rabies in volunteers].
    Lalosević V; Lazarević-Ivanc L; Lalosević D
    Med Pregl; 2001; 54 Suppl 1():23-7. PubMed ID: 12078123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production, purification and analysis of an experimental DNA vaccine against rabies.
    Diogo MM; Ribeiro SC; Queiroz JA; Monteiro GA; Tordo N; Perrin P; Prazeres DM
    J Gene Med; 2001; 3(6):577-84. PubMed ID: 11778904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and safety of a new Vero cell rabies vaccine produced using serum-free medium.
    Costa WA; Cunha RS; Bolzan VL; Silva Ade C; Caporale GM; Chaves LB; Oselka GW; Junqueira DA; Panacho MR; Dias RA; Takaoka NY
    Vaccine; 2007 Nov; 25(48):8140-5. PubMed ID: 18029066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of cytokines in biological preparations.
    Medunitsin NV; Avdeeva JI; Acolzina SE; Alpatova NA; Nevskaya LV
    Biologicals; 2002 Mar; 30(1):1-6. PubMed ID: 11846424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Economical production of rabies vaccine on cell cultures].
    Lalosević D; Lazarević-Ivanc L; Stankov S
    Med Pregl; 1997; 50(11-12):565-8. PubMed ID: 9471524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Titration of serum and antirabies immunoglobulins by the radial immunodiffusion method].
    Mouillot L; Chaniot S; Piat A; Netter R
    Dev Biol Stand; 1978; 40():243-6. PubMed ID: 98374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.